{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:29:50Z","timestamp":1786609790238,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["R01-DK063973"],"award-info":[{"award-number":["R01-DK063973"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK063973"],"award-info":[{"award-number":["R01-DK063973"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS110349"],"award-info":[{"award-number":["R01-NS110349"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The benefit of early diagnosis and treatment has been demonstrated in animal models of several lysosomal storage diseases. In a clinical setting, however, diagnoses are often not made until after patients become symptomatic. The lysosomal storage disease alpha-mannosidosis is caused by a genetic deficiency of lysosomal alpha-mannosidase, leading to the widespread presence of storage lesions throughout the brain and other tissues. In a feline model of alpha-mannosidosis, we previously demonstrated complete correction of the brain following delivery of AAVhu.32-fMANB via the carotid artery in the early symptomatic stage. Here, we investigate the efficacy of AAV gene therapy on globally distributed storage lesions in animals with advanced disease. Some improvements in clinical parameters were observed, however these improvements were less than in animals with less advanced disease. Although the treated animals were improved compared to untreated animals, increasing the vector dose did not further improve clinical outcomes. These results further demonstrate the importance of early detection and treatment of a lysosomal storage disease to successful outcomes. Despite this, partial correction extended the lifespan of diseased cats and may be medically beneficial to patients by slowing or stabilizing the progressive degenerative course of disease.<\/jats:p>","DOI":"10.1038\/s41434-026-00618-0","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:59:54Z","timestamp":1777903194000},"page":"495-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical response to systemic AAV gene therapy in a large animal model of late-stage lysosomal storage disease"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-2118","authenticated-orcid":false,"given":"Jacqueline E.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn M.","family":"Molony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Panek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Vite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Poptani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7497-3943","authenticated-orcid":false,"given":"John H.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10545-013-9622-2","volume":"37","author":"D Malm","year":"2014","unstructured":"Malm D, Stensland HMFR, Edvardsen \u00d8, Nilssen \u00d8. The natural course and complications of alpha-mannosidosis\u2014a retrospective and descriptive study. J Inherit Metab Dis. 2014;37:79\u201382.","journal-title":"J Inherit Metab Dis"},{"key":"618_CR2","doi-asserted-by":"crossref","unstructured":"Wolfe JH. Disorders of glycoprotein degradation: \u03b1-mannosidosis, \u03b2-mannosidosis, fucosidosis, sialidosis, and aspartylglycosaminuria. In: Rosenberg R, Pascual J (eds). Rosenberg\u2019s Molecular and Genetic Basis of Neurological and Psychiatric Disease, vol. 1. Elsevier, 2025, pp 635\u201344.","DOI":"10.1016\/B978-0-443-19041-4.00073-X"},{"key":"618_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-21","volume":"3","author":"D Malm","year":"2008","unstructured":"Malm D, Nilssen \u00d8. Alpha-mannosidosis. Orphanet J Rare Dis. 2008;3:21.","journal-title":"Orphanet J Rare Dis"},{"key":"618_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2024.104927","volume":"68","author":"K\u00f6se","year":"2024","unstructured":"K\u00f6se, Kasapkara E, \u0130nci \u00c7S, Y\u0131ld\u0131z A, Kara Y, \u0130S, et al. Long-term clinical evaluation of patients with alpha-mannosidosis \u2013 A multicenter study. Eur J Med Genet. 2024;68:104927.","journal-title":"Eur J Med Genet"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/bj1890467","volume":"189","author":"LJ Burditt","year":"1980","unstructured":"Burditt LJ, Chotai K, Hirani S, Nugent PG, Winchester BG. Biochemical studies on a case of feline mannosidosis. Biochem J. 1980;189:467\u201373.","journal-title":"Biochem J"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/nen.0b013e31812503b6","volume":"66","author":"AC Crawley","year":"2007","unstructured":"Crawley AC, Walkley SU. Developmental analysis of CNS pathology in the lysosomal storage disease a-mannosidosis. J Neuropathol Exp Neurol. 2007;66:687\u201397.","journal-title":"J Neuropathol Exp Neurol"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1939-1676.1988.tb00311.x","volume":"2","author":"JF Cummings","year":"1988","unstructured":"Cummings JF, Wood PA, de Lahunta A, Walkley SU, Le Boeuf L. The clinical and pathologic heterogeneity of feline alpha-mannosidosis. J Vet Intern Med. 1988;2:163\u201370.","journal-title":"J Vet Intern Med"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/bj1280069","volume":"128","author":"JD Hocking","year":"1972","unstructured":"Hocking JD, Jolly RD, Batt RD. Deficiency of \u03b1-mannosidase in angus cattle. Biochem J. 1972;128:69\u201378.","journal-title":"Biochem J"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/hmg\/8.8.1365","volume":"8","author":"S Stinchi","year":"1999","unstructured":"Stinchi S, L\u00fcllmann-Rauch R, Hartmann D, Coenen R, Beccari T, Orlacchio A, et al. Targeted disruption of the lysosomal \u03b1-mannosidase gene results in mice resembling a mild form of human \u03b1-mannosidosis. Hum Mol Genet. 1999;8:1365\u201372.","journal-title":"Hum Mol Genet"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/BF00692699","volume":"58","author":"M Vandevelde","year":"1982","unstructured":"Vandevelde M, Fankhauser R, Bichsel P, Wiesmann U, Herschkowitz N. Hereditary neurovisceral mannosidosis associated with \u03b1-mannosidase deficiency in a family of persian cats. Acta Neuropathol. 1982;58:64\u201368.","journal-title":"Acta Neuropathol"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/ijms19051500","volume":"19","author":"MR Ceccarini","year":"2018","unstructured":"Ceccarini MR, Codini M, Conte C, Patria F, Cataldi S, Bertelli M, et al. Alpha-mannosidosis: therapeutic strategies. Int J Mol Sci. 2018;19:1500.","journal-title":"Int J Mol Sci"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10545-018-0185-0","volume":"41","author":"L Borgwardt","year":"2018","unstructured":"Borgwardt L, Guffon N, Amraoui Y, Dali CI, De Meirleir L, Gil-Campos M, et al. Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial. J Inherit Metab Dis. 2018;41:1215\u201323.","journal-title":"J Inherit Metab Dis"},{"key":"618_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12799","volume":"48","author":"N Guffon","year":"2025","unstructured":"Guffon N, Borgwardt L, Tylki-Szyma\u0144ska A, Ballabeni A, Don\u00e0 F, Joseph A, et al. Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosis. J Inherit Metab Dis. 2025;48:e12799.","journal-title":"J Inherit Metab Dis"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/hmg\/ddh220","volume":"13","author":"DP Roces","year":"2004","unstructured":"Roces DP, L\u00fcllmann-Rauch R, Peng J, Balducci C, Andersson C, Tollersrud O, et al. Efficacy of enzyme replacement therapy in \u03b1-mannosidosis mice: a preclinical animal study. Hum Mol Genet. 2004;13:1979\u201388.","journal-title":"Hum Mol Genet"},{"key":"618_CR15","first-page":"101272","volume":"32","author":"JE Hunter","year":"2024","unstructured":"Hunter JE, Molony CM, Bagel JH, O\u2019Donnell P, Vite CH, Chawla S, et al. Widespread correction of brain pathology in feline alpha-mannosidosis by dose escalation of intracisternal AAV vector injection. Mol Ther: Methods Clin Dev. 2024;32:101272.","journal-title":"Mol Ther: Methods Clin Dev"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.20392","volume":"57","author":"CH Vite","year":"2005","unstructured":"Vite CH, McGowan JC, Niogi SN, Passini MA, Drobatz KJ, Haskins ME, et al. Effective gene therapy for an inherited CNS disease in a large animal model. Ann Neurol. 2005;57:355\u201364.","journal-title":"Ann Neurol"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/mt.2015.168","volume":"24","author":"SY Yoon","year":"2016","unstructured":"Yoon SY, Bagel JH, O\u2019Donnell PA, Vite CH, Wolfe JH. Clinical improvement of alpha-mannosidosis cat following a single cisterna magna infusion of AAV1. Mol Ther. 2016;24:26\u201333.","journal-title":"Mol Ther"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/awaa161","volume":"143","author":"SY Yoon","year":"2020","unstructured":"Yoon SY, Hunter JE, Chawla S, Clarke DL, Molony C, O\u2019Donnell PA, et al. Global CNS correction in a large brain model of human alpha-mannosidosis by intravascular gene therapy. Brain. 2020;143:2058\u201372.","journal-title":"Brain"},{"key":"618_CR19","first-page":"1","volume":"20","author":"MG Biferi","year":"2021","unstructured":"Biferi MG, Cohen-Tannoudji M, Garc\u00eda-Silva A, Souto-Rodr\u00edguez O, Vi\u00e9itez-Gonz\u00e1lez I, San-Mill\u00e1n-Tejado B, et al. Systemic treatment of fabry disease using a novel AAV9 vector expressing \u03b1-galactosidase A. Mol Ther: Methods Clin Dev. 2021;20:1\u201317.","journal-title":"Mol Ther: Methods Clin Dev"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.gt.3302883","volume":"14","author":"C Sevin","year":"2007","unstructured":"Sevin C, Verot L, Benraiss A, Van Dam D, Bonnin D, Nagels G, et al. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Ther. 2007;14:405\u201314.","journal-title":"Gene Ther"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","volume":"15","author":"MA Cabrera-Salazar","year":"2007","unstructured":"Cabrera-Salazar MA, Roskelley EM, Bu J, Hodges BL, Yew N, Dodge JC, et al. Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease. Mol Ther. 2007;15:1782\u20138.","journal-title":"Mol Ther"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2008.04.022","volume":"213","author":"D Sondhi","year":"2008","unstructured":"Sondhi D, Peterson DA, Edelstein AM, del Fierro K, Hackett NR, Crystal RG. Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis. Exp Neurol. 2008;213:18\u201327.","journal-title":"Exp Neurol"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1182\/blood.V97.6.1625","volume":"97","author":"ML Casal","year":"2001","unstructured":"Casal ML, Wolfe JH. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of \u03b2-glucuronidase can delay onset of clinical signs. Blood. 2001;97:1625\u201334.","journal-title":"Blood"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ymthe.2006.02.012","volume":"14","author":"BA Karolewski","year":"2006","unstructured":"Karolewski BA, Wolfe JH. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII. Mol Ther. 2006;14:14\u201324.","journal-title":"Mol Ther"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.1073\/pnas.192353499","volume":"99","author":"KP Ponder","year":"2002","unstructured":"Ponder KP, Melniczek JR, Xu L, Weil MA, O\u2019Malley TM, O\u2019Donnell PA, et al. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. PNAS. 2002;99:13102\u20137.","journal-title":"PNAS"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa042604","volume":"352","author":"ML Escolar","year":"2005","unstructured":"Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease. N Engl J Med. 2005;352:2069\u201381.","journal-title":"N Engl J Med"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","volume":"89","author":"MD Wright","year":"2017","unstructured":"Wright MD, Poe MD, DeRenzo A, Haldal S, Escolar ML. Developmental outcomes of cord blood transplantation for Krabbe disease. Neurology. 2017;89:1365\u201372.","journal-title":"Neurology"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1007\/s10545-009-9035-4","volume":"33","author":"A Broomfield","year":"2010","unstructured":"Broomfield A, Chakrapani A, Wraith J. The effects of early and late bone marrow transplantation in siblings with alpha-mannosidosis. Is early haematopoietic cell transplantation the preferred treatment option? J Inherit Metab Dis. 2010;33:S123\u2013S127.","journal-title":"J Inherit Metab Dis"},{"key":"618_CR29","first-page":"101552","volume":"33","author":"JE Hunter","year":"2025","unstructured":"Hunter JE, Molony CM, Panek WK, Vite CH, Chawla S, Poptani H, et al. Effect of disease progression on CSF-directed AAV gene therapy in a large brain animal model of lysosomal storage disease. Mol Ther: Methods Clin Dev. 2025;33:101552.","journal-title":"Mol Ther: Methods Clin Dev"},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/mt.2008.166","volume":"16","author":"CN Cearley","year":"2008","unstructured":"Cearley CN, Vandenberghe LH, Parente MK, Carnish ER, Wilson JM, Wolfe JH. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol Ther. 2008;16:1710\u20138.","journal-title":"Mol Ther"},{"key":"618_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","volume":"13","author":"CN Cearley","year":"2006","unstructured":"Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther. 2006;13:528\u201337.","journal-title":"Mol Ther"},{"key":"618_CR32","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","volume":"27","author":"CN Cearley","year":"2007","unstructured":"Cearley CN, Wolfe JH. A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J Neurosci. 2007;27:9928\u201340.","journal-title":"J Neurosci"},{"key":"618_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/gt.2009.52","volume":"16","author":"T Husain","year":"2009","unstructured":"Husain T, Passini M, Parente M, Fraser N, Wolfe J. Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters. Gene Ther. 2009;16:927\u201332.","journal-title":"Gene Ther"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/hum.2010.055","volume":"21","author":"M Lock","year":"2010","unstructured":"Lock M, Alvira M, Vandenberghe LH, Samanta A, Toelen J, Debyser Z, et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther. 2010;21:1259\u201371.","journal-title":"Hum Gene Ther"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/jnen\/60.8.817","volume":"60","author":"CH Vite","year":"2001","unstructured":"Vite CH, McGowan JC, Braund KG, Drobatz KJ, Glickson JD, Wolfe JH, et al. Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis. J Neuropathol Exp Neurol. 2001;60:817\u201328.","journal-title":"J Neuropathol Exp Neurol"},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jnen\/nlv007","volume":"75","author":"M Kumar","year":"2016","unstructured":"Kumar M, Duda JT, Yoon SY, Bagel JH, O\u2019Donnell PA, Vite CH, et al. Diffusion tensor imaging for assessing brain gray and white matter abnormalities in a feline model of a-mannosidosis. J Neuropathol Exp Neurol. 2016;75:35\u201343.","journal-title":"J Neuropathol Exp Neurol"},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/nbm.1430","volume":"23","author":"S Magnitsky","year":"2010","unstructured":"Magnitsky S, Vite CH, Delikatny EJ, Pickup S, Wehrli S, Wolfe JH, et al. Magnetic resonance spectroscopy of the occipital cortex and the cerebellar vermis distinguishes individual cats affected with alpha-mannosidosis from normal cats. NMR Biomed. 2010;23:74\u201379.","journal-title":"NMR Biomed"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3174\/ajnr.A0791","volume":"29","author":"CH Vite","year":"2008","unstructured":"Vite CH, Magnitsky S, Aleman D, O\u2019Donnell P, Cullen K, Ding W, et al. Apparent diffusion coefficient reveals gray and white matter disease, and T2 mapping detects white matter disease in the brain in feline alpha-mannosidosis. Am J Neuroradiol. 2008;29:308\u201313.","journal-title":"Am J Neuroradiol"},{"key":"618_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/mt.2008.57","volume":"16","author":"A Janssen","year":"2008","unstructured":"Janssen A, Min SH, Molday LL, Tanimoto N, Seeliger MW, Hauswirth WW, et al. Effect of late-stage therapy on disease progression in AAV-mediated rescue of photoreceptor cells in the retinoschisin-deficient mouse. Mol Ther. 2008;16:1010\u20137.","journal-title":"Mol Ther"},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1093\/hmg\/ddv354","volume":"24","author":"S Mookherjee","year":"2015","unstructured":"Mookherjee S, Hiriyanna S, Kaneshiro K, Li L, Li Y, Li W, et al. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy. Hum Mol Genet. 2015;24:6446\u201358.","journal-title":"Hum Mol Genet"},{"key":"618_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106111","volume":"181","author":"ME Caulfield","year":"2023","unstructured":"Caulfield ME, Vander Werp MJ, Stancati JA, Collier TJ, Sortwell CE, Sandoval IM, et al. Downregulation of striatal Cav1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age. Neurobiol Dis. 2023;181:106111.","journal-title":"Neurobiol Dis"},{"key":"618_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.30535","volume":"70","author":"O Murillo","year":"2019","unstructured":"Murillo O, Moreno D, Gazquez C, Barberia M, Cenzano I, Navarro I, et al. Liver expression of a MiniATP7B gene results in long-term restoration of copper homeostasis in a Wilson disease model in mice. Hepatology. 2019;70:108\u201326.","journal-title":"Hepatology"},{"key":"618_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ymthe.2020.04.004","volume":"28","author":"K Miyadera","year":"2020","unstructured":"Miyadera K, Conatser L, Llanga TA, Carlin K, O\u2019Donnell P, Bagel J, et al. Intrastromal gene therapy prevents and reverses advanced corneal clouding in a canine model of mucopolysaccharidosis I. Mol Ther. 2020;28:1455\u201363.","journal-title":"Mol Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00618-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:57:10Z","timestamp":1786607830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00618-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00618-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}